# Study to Evaluate SYN115 in Parkinson's Disease

> **NCT00605553** · PHASE2 · COMPLETED · sponsor: **Biotie Therapies Inc.** · enrollment: 30 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** Tozadenant

## Key facts

- **NCT ID:** NCT00605553
- **Lead sponsor:** Biotie Therapies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605553, "Study to Evaluate SYN115 in Parkinson's Disease". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00605553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*